EZH2 and prostate cancer: In addition to the role of transcription regulation, SETD2 is also involved in non‐histone methylation modifications,47, 48 alternative splicing,49 etc. For example, it has been reported that SETD2 can restrict prostate cancer metastasis by integrating EZH2 and AMPK signalling pathways.50